It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Explore various ways to earn money while working remotely. Unlock new income opportunities with flexible options suitable for anyone.
12,183 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
SK Hynix moves to list in the U.S., challenging Micron for memory-chip dominance as AI-driven demand and cyclical dyn...
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Interactive Brokers surged in the first half of 2026 as traders flocked to global markets. This guide breaks down the...
Meta Platforms dominates online ads with a vast social network and deep data insights. This guide explains why it rem...
GE Aerospace delivered strong results in 2026, but the broader XLI index outpaced the stock through July. Here's what...
Dividend income can be a reliable part of a retirement plan. This guide shows the math behind earning $12,000 annuall...
Cornerstone Capital Bank expands its retail mortgage footprint by adding The Wizelman Team led by veteran lender Dary...
A high-stakes pivot: the team behind ethereum's institutional privacy push launches EthSystems, a for-profit venture ...
Rising financed jewelry debt is reshaping family budgets and investment plans. Experts say debt consolidation seldom ...
The Russell 2000 is on track for its strongest year since 2003, outpacing the S&P 500 as AI infrastructure plays lift...
A Utah-based defamation suit accuses Kevin O’Leary and Fox News of tying two local political groups to the CCP amid o...